In the development of anti-breast cancer drugs, the quantitative structure-activity relationship model of compounds is usually used to select potential active compounds. However, the existing methods ...
Explore predictive modeling for compound prioritization, including in silico screening, toxicology models, and lead selection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results